ATOSSA GENETICS INC's gross profit margin for the fourth quarter of its fiscal year 2014 has significantly increased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. ATOSSA GENETICS INC is extremely liquid. Currently, the Quick Ratio is 3.97 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has decreased by 10.41% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY14||Q4 FY13|
|Net Sales ($mil)||0.49||0.05|
|Net Income ($mil)||-5.81||-2.76|
|Balance Sheet||Q4 FY14||Q4 FY13|
|Cash & Equiv. ($mil)||8.5||6.34|
|Total Assets ($mil)||11.76||12.01|
|Total Debt ($mil)||0.13||0.0|
|Profitability||Q4 FY14||Q4 FY13|
|Gross Profit Margin||-664.83||-4850.0|
|Return on Assets||-124.6||-89.8|
|Return on Equity||-154.32||-101.72|
|Debt||Q4 FY14||Q4 FY13|
|Share Data||Q4 FY14||Q4 FY13|
|Shares outstanding (mil)||24.56||18.57|
|Div / share||0.0||0.0|
|Book value / share||0.39||0.57|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1125570.0||473090.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. Conducting a second comparison, its price-to-book ratio of 3.67 indicates a premium versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 7.13. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. The valuation analysis reveals that, ATOSSA GENETICS INC seems to be trading at a premium to investment alternatives within the industry.
|ATOS NM||Peers 36.21||ATOS NM||Peers 29.73|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
ATOS's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
ATOS's P/CF is negative making the measure meaningless.
|ATOS NA||Peers 28.56||ATOS NA||Peers 0.96|
Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.
Ratio not available.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|ATOS 3.67||Peers 7.13||ATOS 10.30||Peers -4.96|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
ATOS is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
ATOS is expected to have an earnings growth rate that significantly exceeds its peers.
|ATOS 65.81||Peers 4.86||ATOS -16.91||Peers 6.36|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ATOS is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
ATOS significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV